Medical technology company Stryker Corporation, headquartered in Kalamazoo, Michigan, USA, has opened an Additive Manufacturing facility in Anngrove, Cork, Ireland, and welcomed Taoiseach Micheál Martin TD, the IDA and other guests to the opening ceremony. The new 14,500 m2 facility will reportedly create capacity for 600 high-tech jobs and position Stryker for further Additive Manufacturing growth.
Stryker specialises in the application of AM in healthcare, particularly for the production of specialised medical devices. The company manufactures products to treat bone-related conditions across knees, hips, shoulder, ankle, craniomaxillofacial and spine, as well as patient-specific solutions for people with significant disease progression often with no alternative.
Along with housing Stryker’s manufacturing facilities, Anngrove is also the worldwide headquarters of the AMagine Institute, which is the centre of excellence for Additive Manufacturing across Stryker. The institute develops innovative technologies, from early research and development to full commercial launch and scaling, and deploys these new technologies across its full portfolio of products and services.
“The new facility and talent will continue to unlock new opportunities that were previously not possible, accelerate innovation globally and further support our mission to make healthcare better together with our customers,” stated Viju Menon, group president Global Quality and Operations at Stryker. “With our experience and proprietary technology, we are excited to impact more patients and drive growth with this additional investment. We are also pleased to expand our talent base in Ireland with engaging roles across a range of disciplines. At Stryker, we are committed to a diverse, safe and inclusive work environment.”
Taoiseach Micheál Martin TD, commented, “I am delighted to be at the opening of Stryker’s newly expanded Anngrove facility, a very welcome development for Cork and the South West region. Today’s opening and announcement of the capacity for new jobs is testament to the capability, dedication and vision of the Stryker team, and of the growth and success of Stryker here. Government will work to ensure Ireland continues to be an attractive location for the med-tech sector, and business in general, supported by our highly-skilled and talented workforce.”
Martin Shanahan, IDA Ireland CEO, added, “Stryker has been innovating in Additive Manufacturing within the MedTech industry for more than twenty years and opened its Anngrove facility in 2016. The expanded facility furthers the company’s four-decade commitment to Ireland and recognises the strong ecosystem of universities, engineering talent and partners such as the IDA. It also builds on Stryker’s outstanding track record for innovation and shows the key role Anngrove plays in the company’s global additive technology research and development. We welcome this exciting development in Anngrove, the potential it brings for future high tech job growth, and look forward to continued success for Stryker in Ireland.”